Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme

Peer Review reports

Original Submission
22 May 2004	Submitted	Original manuscript
16 Jun 2004	Reviewed	Reviewer Report - John Hainsworth
25 Jun 2004	Reviewed	Reviewer Report - Johan Vansteenkiste
11 Jul 2004	Author responded	Author comments - Xin Lin Mu
Resubmission - Version 2
11 Jul 2004	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
28 Jul 2004	Reviewed	Reviewer Report - Johan Vansteenkiste
2 Aug 2004	Reviewed	Reviewer Report - John Hainsworth
9 Aug 2004	Author responded	Author comments - Xin Lin Mu
Resubmission - Version 4
9 Aug 2004	Submitted	Manuscript version 4
18 Aug 2004	Author responded	Author comments - Xin Lin Mu
Resubmission - Version 5
18 Aug 2004	Submitted	Manuscript version 5
19 Aug 2004	Author responded	Author comments - Xin Lin Mu
Resubmission - Version 6
19 Aug 2004	Submitted	Manuscript version 6
Publishing
19 Aug 2004	Editorially accepted
19 Aug 2004	Article published	10.1186/1471-2407-4-51

Back to article page